The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of efficacy of LBL-024, a novel and uniquely designed bispecific antibody against PD-L1 and 4-1BB, combined with etoposide/platinum-based chemotherapy in treatment-naive advanced extrapulmonary neuroendocrine carcinoma (EP-NEC): A multicenter phase Ib/II trial.
 
Ming Lu
No Relationships to Disclose
 
Panpan Zhang
No Relationships to Disclose
 
Bo Liu
No Relationships to Disclose
 
Yuping Sun
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Pfizer; Roche
 
Ning Li
No Relationships to Disclose
 
Shegan Gao
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Jianwei Yang
No Relationships to Disclose
 
Mudan Yang
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Ji Ma
No Relationships to Disclose
 
Peng Zhao
No Relationships to Disclose
 
Wenduo He
Employment - Leads Biolabs
 
Shengli Cai
Employment - Leads Biolabs
Leadership - Leads Biolabs
 
Lin Shen
No Relationships to Disclose